Re­gen­eron, Il­lu­mi­na in­vest in Tru­ve­ta; In­hi­brx Bio’s $150M loan

Plus, news about Biop­ti­mus, RhyGaze, Gri­fols, sub­cu­ta­neous Leqem­bi and Sling Ther­a­peu­tics:

Re­gen­eron pours $119.5M in­to Tru­ve­ta Se­ries C: Re­gen­eron will al­so work with the med­ical …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER